Cite
HARVARD Citation
Papadopoulos, V. et al. (2020). Estimated glomerular filtration rate independently predicts outcome of azacitidine therapy in higher‐risk Myelodysplastic syndromes. Results from 536 patients of the Hellenic National Registry of Myelodysplastic and Hypoplastic syndromes. Hematological oncology. 38 (4), pp. 541-553. [Online].